Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study.
作者信息
Calgüneri M, Oztürk M A, Ertenli I, Kiraz S, Apraş S, Ozbalkan Z
出版信息
Ann Rheum Dis. 2003 May;62(5):492-3. doi: 10.1136/ard.62.5.492.
Abstract
摘要
相似文献
1
Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study.
Ann Rheum Dis. 2003 May;62(5):492-3. doi: 10.1136/ard.62.5.492.
2
Interferon-alpha in the management of patients with Behçet's disease.
Br J Hosp Med (Lond). 2008 Oct;69(10):575-9. doi: 10.12968/hmed.2008.69.10.31317.
3
Low dose interferon-alpha to treat Behçet's disease.
Clin Exp Rheumatol. 2007 Sep-Oct;25(5):791.
4
Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behçet's disease.
Scand J Rheumatol. 2005;34(1):75-6. doi: 10.1080/03009740510017896.
5
The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.
Adv Exp Med Biol. 2003;528:503-9. doi: 10.1007/0-306-48382-3_102.
6
Interferon alfa-associated depression in patients with Behçet's syndrome: a prospective controlled study.
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S175. Epub 2014 Sep 30.
7
Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
J Rheumatol. 2005 Aug;32(8):1633; author reply 1634.
8
Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.
Clin Rheumatol. 2005 Feb;24(1):64-6. doi: 10.1007/s10067-004-0944-1. Epub 2004 Oct 26.
9
[Interferons and Behçet's disease].
Rev Med Interne. 2002 Nov;23 Suppl 4:495s-499s. doi: 10.1016/s0248-8663(02)00665-3.
10
Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):457-65. doi: 10.1007/s00417-014-2856-3. Epub 2014 Dec 12.
引用本文的文献
1
Multiple Venous Thromboses and Renal Failure in Behcet's Disease: A Case Report and Review of the Literature.
Cureus. 2024 Apr 3;16(4):e57560. doi: 10.7759/cureus.57560. eCollection 2024 Apr.
2
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet's uveitis.
Cell Discov. 2024 May 4;10(1):47. doi: 10.1038/s41421-024-00671-2.
3
Advances in pathogenesis and treatment of ocular involvement in Behcet's disease.
Front Immunol. 2023 Sep 29;14:1206959. doi: 10.3389/fimmu.2023.1206959. eCollection 2023.
4
Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.
Int J Mol Sci. 2023 May 3;24(9):8176. doi: 10.3390/ijms24098176.
5
Behçet Disease: An Update for Dermatologists.
Am J Clin Dermatol. 2021 Jul;22(4):477-502. doi: 10.1007/s40257-021-00609-4. Epub 2021 Jun 1.
6
Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach.
Front Med (Lausanne). 2021 Apr 28;8:624795. doi: 10.3389/fmed.2021.624795. eCollection 2021.
7
Experimental Therapeutic Solutions for Behcet's Disease.
J Exp Pharmacol. 2021 Feb 12;13:127-145. doi: 10.2147/JEP.S265645. eCollection 2021.
8
Update on the treatment of Behçet's syndrome.
Intern Emerg Med. 2019 Aug;14(5):661-675. doi: 10.1007/s11739-019-02035-1. Epub 2019 Jan 25.
9
Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.
Int J Rheumatol. 2017;2017:2160610. doi: 10.1155/2017/2160610. Epub 2017 Sep 10.
10
An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.
Orphanet J Rare Dis. 2017 Jul 17;12(1):130. doi: 10.1186/s13023-017-0681-6.
Zotero 插件